How Eli Lilly Wowed With Its Q4 Earnings Results
Eli Lilly (NYSE: LLY) took investors on a roller coaster ride in 2019, with shares swinging by double-digit percentages in both directions. The big drugmaker ended the year on a positive note, though, and entered 2020 with solid momentum.
Now the company has added another reason for investors to be optimistic. Lilly announced its fiscal 2019 fourth-quarter and full-year results before the market opened on Thursday. Here are the highlights of the big pharma company's Q4 update.
Image source: Eli Lilly.
Source Fool.com
